Xiong Nan, Du Yan, Huang Chuncui, Yan Quanyi, Zhao Long, Yang Changjiang, Sun Qing, Gao Zhidong, Wang Caihong, Zhan Jun, Zhang Hongquan, Wang Shan, Ye Yingjiang, Li Yan, Shen Zhanlong
Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, 100044, China.
Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, 100044, China.
Adv Sci (Weinh). 2025 Feb;12(7):e2411740. doi: 10.1002/advs.202411740. Epub 2024 Dec 24.
Liver metastasis is the primary factor contributing to unfavorable prognosis in colorectal cancer (CRC). Although N-glycosylation is implicated in metastasis, there is a notable paucity of comprehensive studies addressing the N-glycosylation proteomics associated with liver metastasis in CRC. In this study, N-glycosylated proteins and N-glycosylation sites of differential expression between primary lesions and paired liver metastatic lesions are identified. Cathepsin D (CTSD) is further screened as a potentially pivotal N-glycosylated protein in CRC liver metastasis. Glycosyltransferases complex DDOST and STT3B can regulate N-glycosylation modification at residue 263 of CTSD (a protease), thereby affecting CTSD protease to lyse ACADM. ACADM can regulate ferroptosis-related proteins (ACSL4, SLC7A11, and GPX4) to further influence the invasion and metastasis of CRC cells. This newly discovered mechanism provides potential therapeutic targets for CRC treatment and insights for controlling CRC progression and metastasis.
肝转移是导致结直肠癌(CRC)预后不良的主要因素。尽管N-糖基化与转移有关,但针对CRC肝转移相关的N-糖基化蛋白质组学的全面研究却明显匮乏。在本研究中,我们鉴定了原发性病变与配对的肝转移病变之间差异表达的N-糖基化蛋白和N-糖基化位点。组织蛋白酶D(CTSD)被进一步筛选为CRC肝转移中潜在的关键N-糖基化蛋白。糖基转移酶复合物DDOST和STT3B可调节CTSD(一种蛋白酶)第263位残基的N-糖基化修饰,从而影响CTSD蛋白酶裂解ACADM。ACADM可调节铁死亡相关蛋白(ACSL4、SLC7A11和GPX4),进而影响CRC细胞的侵袭和转移。这一新发现的机制为CRC治疗提供了潜在的治疗靶点,并为控制CRC进展和转移提供了思路。